Serosurvey of veterinary conference participants for evidence of zoonotic exposure to canine norovirus – study protocol by unknown
Mesquita and Nascimento Virology Journal 2012, 9:250
http://www.virologyj.com/content/9/1/250STUDY PROTOCOL Open AccessSerosurvey of veterinary conference participants
for evidence of zoonotic exposure to canine
norovirus – study protocol
João Rodrigo Mesquita1,2* and Maria São José Nascimento1Abstract
Background: Noroviruses have emerged as the leading cause of outbreaks and sporadic cases of acute
gastroenteritis in humans worldwide. Person-to-person contact and consumption of contaminated food are
considered the most important ways of transmission of noroviruses however zoonotic transmission has been
suggested. Recently, noroviruses have been found in dogs which, unlike bovine and swine noroviruses, may
present a higher risk of zoonotic transfer, given to the often close contacts between humans and pet dogs in many
societies across the world. The present paper describes a seroepidemiologic study aiming to provide information
on the exposure level of humans to canine norovirus.
Methods/Design: A case–control study was designed to address the potential exposure to canine norovirus based
on the presence of antibodies against canine norovirus. Sera from veterinarians (a population repeatedly in close
contact with dogs) will be collected in an annual Veterinary Sciences Congress in Portugal. In addition, sera from
general population will be obtained and used as controls for comparative purposes. All sera will be tested for the
presence of canine norovirus antibodies using a virus-like particle-based enzyme immune assay. Risk factors for
canine norovirus antibodies presence in veterinarians will be investigated through the delivery of an anonymized
questionnaire to the participants.
Discussion: The present study aims to identify seropositive individuals to canine norovirus and to assess risk
profiles among veterinary professionals with occupational exposure to dogs. To our knowledge this is the first study
providing information on the potential zoonotic risk of canine norovirus, thus allowing the development of
preventive measures and ascertaining potential risks for Public Health resulting from contact to dogs.
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Noroviruses are the leading cause of outbreaks and spor-
adic cases of acute gastroenteritis worldwide in humans
[1]. Person-to-person contact and consumption of con-
taminated food are the most important routes of trans-
mission [2,3], however zoonotic transmission has been
recently suggested [4,5].
Both humans and animals shed genetically similar
norovirus strains which raises the questions whether* Correspondence: jmesquita@esav.ipv.pt
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man and vice versa occurs and whether animals repre-
sent a reservoir for noroviruses [6]. In 2005, research-
ers have sought explicit criteria to judge the possibility
of animal infections causing human diseases by per-
forming a qualitative risk assessment of the emerging
zoonotic potential of animal diseases [7]. According to
the proposed algorithm animal noroviruses were cate-
gorized as not zoonotic (grade 0 in a scale of 0 to 4)
[7]. However, additional research has strengthened the
hypothesis for zoonotic transmission primarily based
on the genetic relatedness between human noroviruses
and noroviruses found in swine [4] and the experimen-
tal confirmation of human norovirus replication in
gnotobiotic pigs that also presented diarrhea and fecaloMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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sequences were found to be present in retail meat
samples alerting for a possible route for zoonotic
transmission of noroviruses through the food chain
[8]. Results from these investigations have raised alarm
for norovirus cross-species transmission to humans
through infected domestic animals, and for the emer-
gence of animal/human recombinants [8].
Recently, noroviruses have been described in dogs
from Portugal [9], Italy [10] and Greece [11]. Unlike bo-
vine and swine noroviruses, canine norovirus could rep-
resent a higher risk of zoonotic transfer, given the
intimate interaction between humans and pet dogs in
societies worldwide. Interestingly, researchers from Fin-
land have found that dogs could shed human norovirus
therefore posing as potential carriers for human noro-
virus [12]. Although severe cases are uncommon, zoo-
notic agents that are transmitted due to intimate contact
between pets and humans are widely documented [13],
specially by dogs which are known to play a role in
about 100 zoonotic diseases [14,15].
The anthropozoonotic ability of an infectious agent
has been long inferred by studies identifying specific
antibodies against a pathogen in a human population
that is repeatedly in close contact with a particular ani-
mal and comparison to the antibody level of a matched
control population with no animal association [16].
To the best of our knowledge, since the discovery of
canine norovirus in 2008 [10] no project was approved
or research has been made worldwide concerning the
study of the potential zoonotic exposure to canine noro-
virus. Moreover, the potential for human exposure to ca-
nine norovirus is great, since it has been shown that
noroviruses are widely shed by dogs [17,18].
The project NOVEL CANINE NOROVIRUS: MO-
LECULAR, EPIDEMIOLOGIC AND PATHOGENIC
ASPECTS, is supported by both European and Portu-
guese funding and aims to answer this question by pro-
viding for the first time detailed information on the
exposure level of humans to canine norovirus through
the evaluation of the presence of antibodies to canine
norovirus in human sera in a large-scale case–control
epidemiologic survey. Moreover will aim to compare the
serological responses between two kinds of populations
with high and low-level canine norovirus exposure risk
profiles, respectively small animal veterinarians (that fre-
quently encounter occupational exposures to animal ma-
terial that place them at high risk for zoonoses) and
general population (with no professional exposure to
animals but potentially exposed to household pets).
Finally, the study will investigate the potential risk
factors for canine norovirus exposure among veterin-
ary workers. Overall, this work will address the need
for the development of preventive measures againstthis potentially new zoonotic agent such as viral con-




Sera from veterinarians will be collected in Santa Maria
da Feira, northern Portugal, at a Veterinary Sciences
Congress (VSC) which occurs each year in February.
The VSC is mainly attended by Portuguese veterinarians,
and is generally considered the congress within the Vet-
erinary Sciences with the highest number of participants
in Portugal. The first VSC started in 2005 with 350 par-
ticipants, the second and third VSC (2006 and 2007)
both had 550 participants, the fourth VSC (2008) had
750 participants, the fifth VSC (2009) had 1000 partici-
pants, the sixth VSC (2010) had 1200 participants, the
seventh VSC (2011) had 1300 participants. The growth
of the number of participants in the past years provides
confidence for a substantial number of congress partici-
pants willing to participate in our study. Blood (~5ml)
will be collected by a group of trained nurses by vene-
puncture. Sera will be separated and frozen at −20°C
within 24 hours. Participants will be asked to provide for
signed informed consent in accordance to the Helsinki
Declaration. In order to achieve the highest number of
participants for this study, posters will be fixated and
flyers will be introduced in the participants’ documenta-
tion bag.
For comparative purposes, sera from general popula-
tion will also be studied. These sera will be obtained
from volunteers at the Faculty of Pharmacy of the Uni-
versity of Porto and will include students, technical staff
and Professors. To reduce possible confounding effects
these control sera will be matched by age (5-year age
group), sex and district. The number of sera samples
from the general population will be estimated through
statistical inference and the validity of the control group
will be proven by a χ2 test for unequal odds with Yates’
continuity correction. This test will assess if the differ-
ences of seroprevalence of antibodies to canine noro-
virus among veterinarians and the general population
will be statistically significant therefore confirming that
the control sera will be valid comparison group for sera
from veterinarians.
This study was approved by and ethical commission at
the University of Porto.
Structured questionnaire
Participants will be asked to complete an anonymized
structured questionnaire that will include information
about variables that are considered potentially associated
to zoonotic infections such as professional details (years
in practice, history of needle stick injury with dog blood
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(household dog/other animal during childhood), as well
as demographics (age, sex, and district of residence). To
maintain the anonymity, each serum sample and ques-
tionnaire belonging to the same participant will be given
the same unique number.
Assessment of risk factors for antibody to canine
norovirus seropositivity among veterinarians
In order to characterize putative risk factors for canine
norovirus antibody seropositivity in veterinarians, uni-
variate and multivariate logistic regression analysis will
be performed. Multivariate models will be chosen be-
cause are most informative given that they produce
adjusted odds ratios (aOR) that simultaneously measure
the strength of associations between the multiple risk
factors and the canine norovirus serum antibody pres-
ence. Crude odds ratio (cOR) and aOR will be calculated
to assess the presence of confounding factors. Variables
will be considered independent when the calculated cOR
and aOR are similar. Likelihood ratio test will also be
performed to evaluate statistical significance of risk fac-
tors with more than 2 levels, given its independence
from the variables reference level. All analyses will be
performed using Epicalc package in the R software (R
2.1.2.0) (R Development Core Team, 2010).
Laboratory analysis
Immunoglobulin (Ig) G antibodies to canine norovirus
will be detected by an in-house enzyme immune assay
using recombinant virus-like particles (VLPs) of canine
norovirus as antigens. VLPs will be produced in a
baculovirus-insect cell expression system and purified
through sucrose and CsCl gradients as described else-
where [19]. VLP morphology will be confirmed by elec-
tron microscopy. The antigenicity of VLPs will be tested
by western blot analysis using rabbit hyperimmune anti-
sera against canine norovirus. A checkerboard titration
of canine norovirus VLPs, human sera, and conjugate
(goat anti-human IgG horseradish peroxidase) will be
performed to determine the optimum conditions of the
assay. Sera from both veterinarians and population con-
trols will be tested in duplicate.
Evaluation of cross-reactivity
To investigate the possibility of sera cross-reactivity all
the sera will be tested for the presence of antibodies to
human norovirus by an enzyme immune assay. Crossed-
reactions between canine norovirus and human noro-
virus antibodies will be evaluated using a correlation test
calculated with a 95% significance level, after plotting
data from optical densities in histograms. If optical den-
sities are normally distributed, a Pearson’s correlation
test will be used. If optical densities are not normallydistributed, a Spearman’s correlation test will be chosen.
Analyses will be performed using GraphPad Prism ver.
2.01 software (GraphPad Software, San Diego, CA).
Discussion
In the present study we hypothesize that the outcomes
of the proposed serosurvey may provide unique insight
in the potential exposure of humans to canine norovirus.
In addition, different risk profiles between veterinary
professionals (with occupational contact to dogs) and
the general population will be evaluated. This will pro-
vide valuable data on the potential zoonotic risks of ca-
nine norovirus for humans.
Among veterinary workers, potential risk factors for
canine norovirus infection will also be assessed. This
study will provide important data to support possible
professional/occupational adjustments if needed, to de-
crease risk for exposure to canine norovirus. Finally, this
study will provide more data on the zoonotic exposure
risk and potential preventive measures, such as canine
norovirus control programmes (e.g. quarantines), and
canine norovirus vaccine research and development. It is
also expected to disseminate the results to both public
health (by communicating in National and International
Conferences) and academic stakeholders by publication
of the results in peer-reviewed journals.
Epidemiologic studies studying the norovirus human-
animal interface are rare and the proposed study on ca-
nine norovirus will attempt to fill this knowledge gap.
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